The Food and Drug Administration (FDA) has expanded the approval of Inspire therapy (Inspire Medical Systems) to include patients aged 18 to 21 years with moderate to severe obstructive sleep apnea ...

MINNEAPOLIS, April 21, 2020 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and ...

CHI Memorial is now offering Inspire therapy. Officials said, "This is a breakthrough obstructive sleep apnea (OSA) treatment option for those who cannot use Continuous Positive Airway Pressure (CPAP) ...

Over 22 million Americans suffer from sleep apnea. The causes and intensity of symptoms of sleep apnea vary person to person, so it's important to be aware of the treatment options available.

Credit: Prestige Biopharma. Inspire therapy is a fully implanted neurostimulation device that consists of a small generator, a sensing lead, and a stimulation lead. The Food and Drug Administration ...

Inspire Medical Systems, Inc. (NYSE:INSP) is one of the best medical technology stocks to buy right now. On May 5, Stifel ...

WORCESTER — Do you have problems sleeping? If the answer is yes, you’re not alone. Roughly 14% of adults in the U.S. — more than one of every 10 grownups — had trouble falling sleep most days or every ...

CEO Tim Herbert highlighted the milestone of surpassing 100,000 patients receiving Inspire therapy. He noted that Inspire remains lightly penetrated in its target market and emphasized the significant ...

Bank of America sees a slate of challenges weighing on Inspire Medical’s growth.